✦ LIBER ✦

P8. A payer perspective cost-benefit analysis of felbamate in a managed-care setting

✍ Scribed by E.G. Klein; J.A. Paladino

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PNP6: COST-BENEFIT ANALYSIS OF ORAL ANTI

✍ P Chen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Cost of care for colorectal cancer in Ir

✍ Tilson, L.; Sharp, L.; Usher, C.; Walsh, C.; S, Whyte; O’Ceilleachair, A.; Stuar 📂 Article 📅 2011 🏛 Springer 🌐 French ⚖ 612 KB

A cost analysis of outpatient care for p

✍ Mohamad A Eloubeidi; Rick K Homan; Michael D Martz; Karl E Theobald; Dawn Proven 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 47 KB

PCN48 COST OF CARE FOR COLORECTAL CANCER

✍ L Tilson; L Sharp; C Walsh; A O'Ceilleachair; C Usher; H Comber; M Barry 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

The Implementation of Critical Pathways

✍ Kris Ghosh; Levi S. Downs; Luis A. Padilla; Karuna P. Murray; Leo B. Twiggs; Car 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 39 KB

PDH32: COST IMPACT OF A PRESCRIPTION BEN

✍ R Balkrishnan; WG Byerly 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB